Biomarin Pharmaceutical Inc
BMRN
Revenue
745.74M
▲33.71M▲4.73%
3 Months ChangeAssets
6.85B
▼-215.93M▼-3.06%
3 Months ChangeLiabilities
1.44B
▼-343.02M▼-19.26%
3 Months ChangeFree Cash Flow
20.87M
▲119.26M▲121.21%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 10-Q
ID: 0001048477-24-000152
2024-10-29
Form 8-K
ID: 0001048477-24-000149
2024-09-24
Form 8-K
ID: 0001193125-24-224139
2024-09-04
Form 8-K
ID: 0001048477-24-000136
2024-08-28
Form 8-K
ID: 0001048477-24-000132
2024-08-22
Form 8-K
ID: 0001193125-24-205405
2024-08-05
Form 10-Q
ID: 0001048477-24-000126
2024-08-05
Form 8-K
ID: 0001048477-24-000125
2024-05-24
Form 8-K
ID: 0001193125-24-147013
2024-05-14
Form 8-K
ID: 0001048477-24-000082